CHAIR
:
SPEAKER
(S):
Shyam Bishen, PhD, MBA, Vice-President Business Devel , Ranbaxy Pharmaceuticals, Inc
Tony Chen, JD, Partner , Jones Day
Nishith Desai, JD, Managing Partner , Nishith Desai Associates
Description
"In the coming years, China and India will be world leaders in the development of new technologies. Both countries' publicly funded R&D budgets are growing by leaps and bounds, with increases as a percent of rapidly growing GDP slated to continue until at least 2010. However, the intellectual property realm remains opaque with radical differences in approach taken by both countries, evolving IP norms and confusion across the board for local players and multinational companies alike. How can biotechnology companies eager to advance science responsibly partner with researchers in these young, exceptionally promising markets? Join experts from these markets as well as companies blazing the trail to responsible technology-sharing in a discussion of the opportunity, tips and tricks for negotiating the licensing process and suggestions on how companies in established markets can influence policy with respect to standardizing technology rights."
Objective1:Discuss the opportunity for new technologies being developed in China and India.
Objective2:Present the challenges of navigating tech transfer in each country.
Objective3:Provide suggestions for ensuring the most successful deals for all parties.